Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
Mats NågårdMei-Lin Ah-SeeJames StraussTrisha Wise-DraperHoward P SafranLaura NadeauWilliam J EdenfieldLionel D LewisLone H OttesenYan LiGanesh M MugunduPublished in: Cancer chemotherapy and pharmacology (2023)
GOV: NCT03333824.
Keyphrases